Additional risk minimisation measures for Ruconest - European survey of educational materials

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000000680
• Study ID:
  1000000680
• Official title and acronym:
  Additional risk minimisation measures for Ruconest - European survey of educational materials
• DARWIN EU® study:
  No
• Study countries:
  European Union

  United Kingdom
• Study description:
  Study is to evaluate the effectiveness of the risk minimisation materials for Ruconest distributed to treatment centres/prescribing physicians in EU/UK countries where Ruconest self-administration kit is launched
• Study status:
  Finalised

Research institutions and networks

Institutions

Pharming Technologies

Study timelines

Date when funding contract was signed

Planned:28/02/2020

Actual:11/02/2020

Study start date

Planned:18/09/2020

Actual:18/12/2020

Date of final study report

Planned:31/01/2026

Actual:26/01/2026

Sources of funding

Pharmaceutical company and other private sector 

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)